Top

Global Hormone Replacement Therapy Market 2015-2019

Category : Healthcare  | Published Date : Nov-2015 | Pages : 69
enquire GET DISCOUNT
Global Hormone Replacement Therapy Market 2015-2019
Covering: An in-depth study of the global hormone replacement therapy market and segmentation by type of hormonal therapy (estrogen replacement therapy and growth hormone replacement therapy), by route of administration (oral, parenteral, and transdermal), and by geography (the Americas, EMEA, and APAC). The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the market, including F. Hoffmann-La Roche, Merck Serono, Novartis, Novo Nordisk, and Pfizer.

An overview of the hormone replacement therapy market
Hormone replacement therapy involves the replacement of the hormones in the body whose levels have become low, in case of women nearing menopause or patient with growth hormone deficiency due to conditions such as dwarfism. At present, the combination of drugs are used to treat the conditions, which are known to have a better safety and efficacy parameter. Unmet medical needs is one of the major drivers influencing the growth of the market. Therefore, the need for new treatment options with better safety results to accommodate the current unmet need is huge.

In 2014, the Americas dominated the market, where the majority of the contribution was from the US, and this trend is expected to continue during the forecast period. However, the market in the APAC region is witnessing a rapid growth, hence, there is a vast opportunity for vendors to venture into this region. Technavio expects the global hormone replacement therapy market to grow at a moderate rate, posting a CAGR of over 2% during the forecast period.

Segmentation of the hormone replacement therapy market by type of hormonal therapy
• Estrogen replacement therapy
• Growth hormone replacement therapy

With a market share of more than 60% the estrogen replacement therapy segment dominate the hormone replacement therapy market. Estrogen replacement therapy is a type of therapy in which estrogen hormones are commonly used to treat the symptoms of menopause. It helps in the reduction of short-term changes of menopause such as hot flashes, disturbed sleep, and vaginal dryness.

Segmentation of the hormone replacement therapy market by route of administration
• Oral
• Parenteral
• Transdermal

The oral route of administration is a sub-division of enteral administration and is regarded as one of the safest and most preferred routes of drug administration. Some of the drug that are administered orally are Premarin and Estrace.

Competitive landscape and key vendors
The global hormone replacement therapy market is a mature market, which is extremely competitive due to the presence of a huge number of small and large vendors. Therefore, development of low-dose oral drugs and locally acting transdermal hormonal replacement products with high efficacy is expected to captivate the attention of players in the hormonal replacement market.

Key vendors in this market are - 
• F. Hoffmann-La Roche
• Merck Serono
• Novartis
• Novo Nordisk
• Pfizer

Other prominent vendors included in this report are Abbott Laboratories, Amgen, ANI Pharmaceuticals, Bayer, Eli Lilly, Hisamitsu Pharmaceutical, Ipsen, Merck, Mylan Laboratories, Orion, QuatRx Pharmaceuticals, Teva Pharmaceutical Industries, and TherapeuticsMD.

Key questions answered in the report include
• What will the market size and the growth rate be in 2019?
• What are the key factors driving the global hormone replacement therapy market?
• What are the key market trends impacting the growth of the global hormone replacement therapy market? 
• What are the challenges to market growth?
• Who are the key vendors in the global hormone replacement therapy market?
• What are the market opportunities and threats faced by the vendors in the global hormone replacement therapy market?
• What are the trending factors influencing the market shares of the Americas, EMEA, and APAC?
• What are the key outcomes of the five forces analysis of the global hormone replacement therapy market?

Technavio also offers customization on reports based on specific client requirement.

Related reports
• Human Growth Hormone Market in the US 2015-2019
• Global Hyperbaric Oxygen Therapy Devices Market: Industry Analysis 2015-2019
• Global Cardiac Resynchronization Therapy (CRT) Devices Market 2015-2019
• Global Human Growth Hormone Market 2015-2019
• Global Heart Valve Repair and Replacement Market 2014-2018
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 06: Market segmentation by type of hormonal therapy
Estrogen replacement therapy
Growth hormone replacement therapy
PART 07: Market segmentation by route of administration
Oral
Parenteral
Transdermal
PART 08: Global estrogen replacement therapy market
Market overview
Market size and forecast
PART 09: Global growth hormone replacement therapy market
Market overview
Market size and forecast
PART 10: Geographical segmentation
Hormone replacement therapy market in Americas
Hormone replacement therapy market in EMEA
Hormone replacement therapy market in APAC
PART 11: Market drivers
Unmet medical needs
Advances in technology
Reformulation of approved drugs
Lifestyle changes
PART 12: Impact of drivers
PART 13: Market challenges
High cost of therapy
Adverse effects
Storage issues
Weak pipeline
PART 14: Impact of drivers and challenges
PART 15: Market trends
Novel drug delivery mechanisms
Paradigm shift toward non-hormonal therapies
Mergers and acquisitions
PART 16: Vendor landscape
Competitive scenario
Key news
Mergers and acquisitions
Market share analysis 2014
Other prominent vendors
PART 17: Key vendor analysis
F. Hoffmann-La Roche
Merck Serono
Novartis
Novo Nordisk
PART 18: Appendix
List of abbreviation
PART 19: Explore Technavio
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Global hormone replacement therapy market 2014-2019 ($ millions)
Exhibit 03: Five forces analysis
Exhibit 04: Global hormone replacement therapy market segmentation by type of hormonal therapy, 2014 (%)
Exhibit 05: Global hormone replacement therapy market segmentation by type of hormonal therapy 2014-2019 ($ millions)
Exhibit 06: Global hormone replacement therapy market by route of administration
Exhibit 07: Global estrogen replacement therapy market 2014-2019 ($ millions)
Exhibit 08: Global growth hormone replacement therapy market 2014-2019 ($ millions)
Exhibit 09: Global hormone replacement therapy market by geography, 2014
Exhibit 10: Global hormone replacement therapy market by key geographies, 2014-2019 ($ millions)
Exhibit 11: Hormone replacement therapy market in Americas 2014-2019 ($ millions)
Exhibit 12: Hormone replacement therapy market in EMEA 2014-2019 ($ millions)
Exhibit 13: Hormone replacement therapy market in APAC 2014-2019 ($ millions)
Exhibit 14: Impact of drivers
Exhibit 15: Impact of drivers and challenges
Exhibit 16: Global sales of Nutropin 2012-2014 ($ millions)
Exhibit 17: Key takeaways: F. Hoffmann-La Roche
Exhibit 18: Global sales of Saizen 2012-2014 ($ millions)
Exhibit 19: Global sales of Gonal-f 2012-2014 ($ millions)
Exhibit 20: Key takeaways: Merck Serono
Exhibit 21: Key takeaways: Novartis
Exhibit 22: Global sales of Norditropin 2012-2014 ($ millions)
Exhibit 23: Key takeaways: Novo Nordisk
Exhibit 24: Global sales of Genotropin 2012-2014 ($ millions)
Exhibit 25: Global sales of Premarin 2012-2014 ($ millions)
Exhibit 26: Global sales of Depo Provera 2012-2014 ($ millions)
Exhibit 27: Key takeaways: Pfizer
Exhibit 28: Merck Serono: Product segmentation 2014
Exhibit 29: Merck Serono: Geographical segmentation by revenue 2014
Exhibit 30: Business segmentation by revenue in percentage, 2014
Exhibit 31: Novo Nordisk: Business segmentation by revenue 2013 and 2014
Exhibit 32: Novo Nordisk: Geographical segmentation by revenue 2014
Exhibit 33: Novo Nordisk: R&D expenditure 2014
...
Publisher Name : Technavio

SIMILAR MARKET STUDIES

Please Select Format
Single User: US $ 2500
Five User: US $ 3000
Site User: US $ 4000
Global User: US $ 10000

NEED MORE INFORMATION
Contact us
Call us +1-971-202-1575
--- or ---
help@bigmarketresearch.com
WHY BIG MARKET RESEARCH
With high quality and penned to perfection, Big Market Research is an exclusive online market to get best market research reports for your business needs and strategies. We recommend you to stop browsing as soon as you discover our website. This is because we firmly believe that once you reach here; all your business concerns will be addressed.

We have a huge collection of market research report from numerous filed which will provide you with all the necessary solution. We make sure that reports that we sell are true in context, have a quality that is unrivaled, fully integrated with equal spread of opinion. They will give you proper insights into different opportunities one may locate for their start-up pr expansion.

Let your qualms and concern be sidelined through our high end syndicated as well as customized reports.
Top